Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 2,831 | 24,741 | 7,543 | 3,578 | 4,658 |
| Gross Profit | 2,831 | 24,741 | 7,543 | 3,578 | 4,658 |
| Operating Expenses | 27,834 | 32,496 | 32,091 | 55,122 | 80,821 |
| Operating Income | -25,003 | -7,755 | -24,548 | -51,544 | -76,163 |
| Interest Expense | 1,072 | -202 | 2,399 | 1,758 | 2,216 |
| Other Income | 1,093 | 1,933 | 1,830 | 67 | 2,291 |
| Pre-tax Income | -24,982 | -5,620 | -25,117 | -53,235 | -76,088 |
| Net Income Continuous | -24,982 | -5,620 | -25,117 | -53,235 | -76,088 |
| Net Income | $-24,982 | $-5,620 | $-25,117 | $-53,235 | $-76,088 |
| EPS Basic Total Ops | -0.26 | 0.03 | -0.28 | -0.63 | -0.92 |
| EPS Basic Continuous Ops | -0.26 | 0.02 | -0.28 | -0.63 | -0.92 |
| EPS Diluted Total Ops | -0.26 | 0.03 | -0.28 | -0.63 | -0.92 |
| EPS Diluted Continuous Ops | -0.26 | 0.02 | -0.28 | -0.63 | -0.92 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.06 | -0.28 | -0.63 | -0.43 |
| EBITDA(a) | $-24,520 | $-6,950 | $-23,889 | $-49,967 | $-74,829 |